Randomized controlled trial of Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus-genotype 4 among Egyptian patients.

被引:0
|
作者
Thakeb, FIA
Omar, MM
El Awady, MM
Isshak, SY
机构
[1] Cairo Univ, Cairo, Egypt
[2] Theidor Bilharz Res Inst, Cairo, Egypt
[3] Acad Res & Sci, Cairo, Egypt
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
252
引用
收藏
页码:278A / 278A
页数:1
相关论文
共 50 条
  • [1] Peginterferon alfa-2a plus Low Dose Ribavirin versus Peginterferon alfa-2a Monotherapy for Dialysis Patients with Hepatitis C Virus Genotype 1 Infection: A Randomized Trial
    Liu, Chen-Hua
    Liang, Cheng-Chao
    Su, Tung-Hung
    Hung, Peir-Haur
    Tsai, Hung-Bin
    Liu, Chun-Jen
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    HEPATOLOGY, 2012, 56 : 993A - 993A
  • [2] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
    Rakov, NE
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
  • [3] Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection
    Marcellin, Patrick
    Cooper, Curtis
    Balart, Luis
    Larrey, Dominique
    Box, Terry
    Yoshida, Eric
    Lawitz, Eric
    Buggisch, Peter
    Ferenci, Peter
    Weltman, Martin
    Labriola-Tompkins, Emily
    Le Pogam, Sophie
    Najera, Isabel
    Thomas, Denise
    Hooper, Gregory
    Shulman, Nancy S.
    Zhang, Ying
    Navarro, Mercidita T.
    Lim, Chin Yin
    Brunda, Michael
    Terrault, Norah A.
    Yetzer, Ellen S.
    GASTROENTEROLOGY, 2013, 145 (04) : 790 - +
  • [4] Chronic hepatitis C genotype 4:: Efficacy and safety of the treatment with peginterferon alfa-2a plus ribavirin
    Diago, M.
    Boadas, J.
    Planas, R.
    Sola, R.
    del Olmo, J. A.
    Crespo, J.
    Erdozain, J. C.
    Anton, M. D.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S292 - S292
  • [5] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried, MW
    Shiffman, ML
    Reddy, KR
    Smith, C
    Marinos, G
    Goncales, FL
    Haussinger, D
    Diago, M
    Carosi, G
    Dhumeaux, D
    Craxi, A
    Lin, A
    Hoffman, J
    Yu, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13): : 975 - 982
  • [6] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C - Reply
    Fried, MW
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 260 - 260
  • [7] Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients
    Nelson, David R.
    Zeuzem, Stefan
    Andreone, Pietro
    Ferenci, Peter
    Herring, Robert
    Jensen, Donald M.
    Marcellin, Patrick
    Pockros, Paul J.
    Rodriguez-Torres, Maribel
    Rossaro, Lorenzo
    Rustgi, Vinod K.
    Sepe, Thomas
    Sulkowski, Mark
    Thomason, Isaac R.
    Yoshida, Eric M.
    Chan, Anna
    Hill, George
    ANNALS OF HEPATOLOGY, 2012, 11 (01) : 15 - 31
  • [8] Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C:: a randomized controlled trial
    Bruno, S
    Cammà, C
    Di Marco, V
    Rumi, M
    Vinci, M
    Camozzi, M
    Rebucci, C
    Di Bona, D
    Colombo, M
    Craxì, A
    Mondelli, MU
    Pinzello, G
    JOURNAL OF HEPATOLOGY, 2004, 41 (03) : 474 - 481
  • [9] Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan
    Lin, Jung-An
    Chen, Yeu-Chin
    Cheng, Shin-Nan
    Chen, Peng-Jen
    Chu, Heng-Cheng
    Hsieh, Tsai-Yuan
    Shih, Yu-Lueng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (10) : 727 - 733
  • [10] Peginterferon alfa-2a with or without Low Dose Ribavirin for Hemodialysis Patients with Hepatitis C Virus Genotype 2 Infection: A Randomized Trial
    Liu, Chen-Hua
    Huang, Chung-Feng
    Liu, Chun-Jen
    Dai, Chia-Yen
    Liang, Cheng-Chao
    Huang, Jee-Fu
    Hung, Peir-Haur
    Tsai, Hung-Bin
    Tsai, Meng-Kun
    Chen, Shih-I
    Yang, Sheng-Shun
    Su, Tung-Hung
    Yang, Hung-Chih
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Chuang, Wan-Long
    Yu, Ming-Lung
    Kao, Jia-Horng
    HEPATOLOGY, 2013, 58 : 1096A - 1096A